n-methyl-3,4-methylenedioxyamphetamine has been researched along with 1-(3-trifluoromethylphenyl)piperazine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Insel, TR; Winslow, JT | 1 |
| Schechter, MD | 1 |
| Cuddy, ML | 1 |
| Baumann, MH; Blough, BE; Dempsey, AG; Nagpal, AS; Partilla, JS; Rothman, RB | 1 |
| Coop, A; Fantegrossi, WE; Katz, EB; Yarosh, HL | 1 |
| Button, J; Dargan, PI; Holt, DW; Lidder, S; Ramsey, J; Wood, DM | 1 |
| Costantino, AG; Logan, BK; Rieders, EF; Sanders, D | 1 |
| Cockburn, AK; Livingstone, AC; Maskell, PD; Pounder, DJ; Preece, J; Seetohul, LN | 1 |
1 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and 1-(3-trifluoromethylphenyl)piperazine
| Article | Year |
|---|---|
Common drugs of abuse--Part II.
Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug and Narcotic Control; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Phenylpropanolamine; Piperazines; Psilocybin; Quetiapine Fumarate; Sodium Oxybate; Substance-Related Disorders; United States | 2004 |
7 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and 1-(3-trifluoromethylphenyl)piperazine
| Article | Year |
|---|---|
Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Tetrahydronaphthalenes; Ultrasonics; Vocalization, Animal | 1990 |
Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Ibogaine; Male; Methoxydimethyltryptamines; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Quipazine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 1997 |
Interaction of amphetamines and related compounds at the vesicular monoamine transporter.
Topics: Amphetamines; Animals; Caudate Nucleus; Dopamine; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Rats; Tetrabenazine; Tyramine; Vesicular Monoamine Transport Proteins | 2006 |
MDMA-like behavioral effects of N-substituted piperazines in the mouse.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Cues; Data Interpretation, Statistical; Discrimination, Psychological; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hallucinogens; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Stereoisomerism | 2007 |
Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
Topics: Adolescent; Bruxism; Dissociative Disorders; Electrocardiography; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Pupil; Substance-Related Disorders; Sympathomimetics; Tachycardia; Young Adult | 2008 |
Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine.
Topics: Antidepressive Agents; Cross Reactions; False Positive Reactions; Hallucinogens; Humans; Illicit Drugs; Immunoassay; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Reagent Kits, Diagnostic; Substance Abuse Detection; Substance-Related Disorders; Trazodone | 2010 |
Stability of 3,4-methylenedioxymethampetamine (MDMA), 4-methylmethcathinone (mephedrone) and 3-trifluromethylphenylpiperazine (3-TFMPP) in formalin solution.
Topics: Calibration; Chromatography, High Pressure Liquid; Designer Drugs; Drug Stability; Formaldehyde; Hallucinogens; Hydrogen-Ion Concentration; Indicators and Reagents; Mass Spectrometry; Methamphetamine; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Quality Control; Reference Standards; Reproducibility of Results; Serotonin Receptor Agonists; Solutions | 2013 |